Assembly Biosciences Inc.

NASDAQ: ASMB · Real-Time Price · USD
25.29
0.33 (1.32%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.85%
After-hours: Aug 15, 2025, 07:52 PM EDT

Assembly Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-38.96M -39.92M -40.18M -40.8M -45.61M -51.35M -61.23M -72.66M -81.39M -88.95M -93.09M -130.95M -126.61M -125.75M -129.85M -109.02M -93.56M -62.7M
Depreciation & Amortization
130K 130K 129K 181K 264K 358K 450K 490K 508K 502K 498K 494K 479K 479K 466K 660K 681K 683K
Stock-Based Compensation
3.09M 3.09M 3.12M 3.33M 3.67M 4.02M 5.12M 6.17M 6.59M 6.99M 6.59M 6.53M 6.56M 6.97M 5.24M 7.04M 11.49M 16.64M
Other Working Capital
9.6M 3.27M 9.22M 82.92M 67.02M 77.68M 88.14M 3.67M 6.74M 5.27M -1.35M 919K 172.22M 361M 573.71M 772.14M 607.83M 380.14M
Other Non-Cash Items
-38.91M -31.31M -22.26M -20.48M 1.86M -590K 581K -174K 192K 3.42M 3.66M 42.6M 42.63M 42.57M 42.66M 6.44M 6.69M 6.95M
Deferred Income Tax
n/a n/a n/a -1.47M -1.78M -1.95M -1.95M -482K -169K n/a n/a -2.53M -2.38M -2.21M -508K 2.1M 1.97M 1.83M
Change in Working Capital
9.67M 3.46M 9.38M 83.5M 67.25M 77.86M 79.77M -3.5M -1.87M -2.35M -2.12M -708K -4.3M -9.61M -11.4M -6.53M 2.95M -34.49M
Operating Cash Flow
-55.85M -56.19M -51.12M 22.94M 24.33M 27.81M 22.74M -70.16M -76.13M -80.39M -84.46M -84.57M -83.63M -87.55M -93.4M -99.3M -69.78M -71.08M
Capital Expenditures
n/a -14K -28K -99K -235K -269K -255K -286K -252K -204K -204K -120K -18K -18K -3.1M -4.83M -4.83M -5.23M
Cash Acquisitions
n/a n/a n/a 24K 4.98K 52.98K 52.98K 28.98K 16.47K -31.53K -31.53K 554.47K 586K 586K 1.44M 2.61M 2.61M 2.61M
Purchase of Investments
-96.91M -110.21M -93.57M -160.98M -145.85M -137.64M -133.97M -34.43M -34.74M -23.68M -27.58M -71.79M -91.5M -115.18M -160.45M -147.65M -233.75M -198.16M
Sales Maturities Of Investments
134.33M 136.13M 130.7M 115.2M 97.67M 76.02M 65.02M 70.14M 82.97M 89.83M 116.83M 136M 144.25M 155.25M 187.7M 207.33M 223.48M 267.93M
Other Investing Acitivies
3.95M 8.69M 9.45M -80.13M -83.18M -88.35M -89.56M 1.63M 1.64M 11.28M 44.28M 43.59M 63.63M 50.95M 18.75M 16.09M -3.98M 76.06M
Investing Cash Flow
41.37M 29.48M 40.17M -42.79M -48.39M -61.87M -69.14M 37.08M 49.63M 67.59M 90.64M 65.59M 54.23M 41.55M 26.52M 55.71M -14.24M 65.39M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-11.94M -12.24M -12.24M -12.29M 108K 129K 129K 192K 192K 289K 289K 291K 291K 258K 258K 5.83M 6.67M 7.48M
Financial Cash Flow
19.27M 31.37M 29.45M 21.65M 21.65M 9.33M 13.82M 5.06M 5.06M 5.11M 614K 2.89M 12.95M 18.93M 53.06M 56.04M 46.83M 41.62M
Net Cash Flow
4.8M 4.66M 18.5M 4.49M 281K -22.04M -29.88M -28.02M -21.44M -7.69M 6.79M -16.09M -16.45M -27.08M -13.82M 12.45M -37.19M 35.93M
Free Cash Flow
-55.85M -56.21M -51.15M 22.84M 24.1M 27.54M 22.49M -70.44M -76.38M -80.59M -84.67M -84.69M -83.65M -87.57M -96.49M -104.13M -74.6M -76.32M